机构:[1]Laboratory of Molecular Cardiology, Department of Cardiology, The FirstAffiliated Hospital of Kunming Medical University, Kunming 650032, China[2]Yunnan Institute of Microbiology, Yunnan University, Kunming 650091,China[3]Department of Cardiovascular Surgery, The First Affiliated Hospital ofKunming Medical University, Kunming 650032, China昆明医科大学附属第一医院[4]Department ofMathematics and Computer Science, Basic Medical College, KunmingMedical University, Kunming 650500, China
Background: Rheumatic heart disease (RHD) is an autoimmune disease triggered by acute rheumatic fever (ARF). Matrix metalloproteinases (MMPs) play an important role in the modulation of immune responses. The purpose of this study was to evaluate the association of MMP1, 3, and 12 promoter polymorphisms with RHD in a Han population in Southern China since the 3 genes are localized on the same chromosome and have a combined effect. Methods: DNA samples were obtained from 90 adult patients with RHD and 90 control subjects. Polymorphisms in MMP1 (rs1799750), MMP3 (rs3025058), and MMP12 (rs2276109) were genotyped by direct sequencing. Differences in genotype and allele frequencies of these polymorphisms were compared between the cases and the controls using Unconditional logistic regression models and Chi-squared test. Results: The 2G/2G genotype of rs1799750 in MMP1 was associated with a significantly higher risk of RHD when compared with the 1G/1G genotype (OR = 3.227; 95% CI:1.118-9.31; p = 0.03). The frequency of allele 2G was higher in patients with RHD compared to the controls (69.4% vs. 58.9%; p = 0.048) No significant differences in genotype and allele frequencies of rs3025058 in MMP3 and rs2276109 in MMP12 were found between the patients with RHD and the controls (p > 0.05). Conclusions: Our results suggest that rs1799750 in MMP1 might be a risk factor for RHD in a Han population in Southern China, and individuals carrying the 2G/2G genotype are likely more susceptible to RHD. In contrast, rs3025058 in MMP3 and rs2276109 in MMP12 might not contribute to the risk of developing RHD in this population. Further studies with larger samples and other ethnic populations are required to confirm these findings.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China [30860278, 81160025, 81560075]; Leading Talent Program of Yunnan Province [L-201203]; Department of Science and Technology of Yunnan Province [2011CI 057]; Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University [2012FB005]; Department of Education of Yunnan Province [ZD2010007]
第一作者机构:[1]Laboratory of Molecular Cardiology, Department of Cardiology, The FirstAffiliated Hospital of Kunming Medical University, Kunming 650032, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Hu Wei,Ye Yujia,Yin Yirui,et al.Association of matrix metalloprotease 1, 3, and 12 polymorphisms with rheumatic heart disease in a Chinese Han population[J].BMC MEDICAL GENETICS.2018,19:doi:10.1186/s12881-018-0538-4.
APA:
Hu, Wei,Ye, Yujia,Yin, Yirui,Sang, Peng,Li, Linhua...&Meng, Zhaohui.(2018).Association of matrix metalloprotease 1, 3, and 12 polymorphisms with rheumatic heart disease in a Chinese Han population.BMC MEDICAL GENETICS,19,
MLA:
Hu, Wei,et al."Association of matrix metalloprotease 1, 3, and 12 polymorphisms with rheumatic heart disease in a Chinese Han population".BMC MEDICAL GENETICS 19.(2018)